Technical Analysis for MYNZ - Mainz Biomed B.V.

Grade Last Price % Change Price Change
F 0.23 -7.31% -0.02
MYNZ closed down 7.31 percent on Friday, November 1, 2024, on 1.46 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -7.31%
Oversold Stochastic Weakness -7.31%
Stochastic Buy Signal Bullish -10.94%
NR7 Range Contraction -10.94%
Inside Day Range Contraction -10.94%

   Recent Intraday Alerts

Alert Time
Fell Below Lower Bollinger Band about 17 hours ago
Possible NR7 about 18 hours ago
2x Volume Pace about 22 hours ago
1.5x Volume Pace about 22 hours ago
3x Volume Pace about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Molecular Diagnostics Diagnostic Tests Cancer Screening Innogenetics

Is MYNZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.3923
52 Week Low 0.1852
Average Volume 2,335,940
200-Day Moving Average 0.63
50-Day Moving Average 0.29
20-Day Moving Average 0.29
10-Day Moving Average 0.27
Average True Range 0.04
RSI (14) 38.65
ADX 12.37
+DI 15.36
-DI 20.22
Chandelier Exit (Long, 3 ATRs) 0.28
Chandelier Exit (Short, 3 ATRs) 0.34
Upper Bollinger Bands 0.36
Lower Bollinger Band 0.22
Percent B (%b) 0.04
BandWidth 46.79
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram -0.0063
Fundamentals Value
Market Cap 4.62 Million
Num Shares 20.4 Million
EPS -1.92
Price-to-Earnings (P/E) Ratio -0.12
Price-to-Sales 24.92
Price-to-Book 6.79
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.26
Resistance 3 (R3) 0.26 0.25 0.25
Resistance 2 (R2) 0.25 0.24 0.25 0.25
Resistance 1 (R1) 0.24 0.24 0.24 0.24 0.25
Pivot Point 0.23 0.23 0.23 0.23 0.23
Support 1 (S1) 0.22 0.22 0.21 0.22 0.20
Support 2 (S2) 0.21 0.22 0.21 0.20
Support 3 (S3) 0.20 0.21 0.20
Support 4 (S4) 0.20